Further evidence was provided by in vivo study, which showed that disruption of Gli1 reversed myeloid Foxo1 deficiency-mediated cytoprotection, evidenced by augmented IR-induced liver injury and enhanced NEK7/NLRP3 activity. The gene discussed is FOXO1; the disease is injury.